参考文献/References:
[1]Skirnisdottir I,Garmo H,Wilander E,et al.Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer.Int J Cancer,2008,123(8):1897-1901.
[2]Mangili G,Somigliana E,Giorgione V,et al.Fertility preservation in women with borderline ovarian tumours.Cancer Treat Rev,2016,49:13-24.
[3]Vasconcelos I,de Sousa MM.Conservative surgery in ovarian borderline tumours:a metaanalysis with emphasis on recurrence risk.Eur J Cancer,2015,51(5):620-631.
[4]May J,Skorupskaite K,Congiu M,et al.Borderline ovarian tumors:fifteen years’ experience at a Scottish tertiary cancer center.Int J Gynecol Cancer,2018,28(9):1683-1691.
[5]Armstrong DK,Alvarez RD,BakkumGamez JN,et al.NCCN guidelines insights:ovarian cancer,version 1.2019.J Natl Compr Canc Netw,2019,17(8):896-909.
[6]Gradishar WJ,Anderson BO,Abraham J,et al.Breast cancer,version 3.2020,NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw,2020,18(4):452-478.
[7]中国优生科学协会肿瘤生殖学分会.交界性卵巢肿瘤诊治专家共识.中国实用妇科与产科杂志，2019,35(9):1000-1007.
[8]Vasconcelos I,de Sousa MM.Conservative surgery in ovarian borderline tumours: a metaanalysis with emphasis on recurrence risk.Eur J Cancer,2015,51(5):620-631.
[9]Chevrot A,Hequet D,Fauconnier A,et al.Impact of surgical restaging on recurrence in patients with borderline ovarian tumors:a metaanalysis.Eur J Obstet Gynecol Reprod Biol,2020,248:227-232.
[10]Bercow A,Nitecki R,Brady PC,et al.Outcomes after fertilitysparing surgery for women with ovarian cancer: a systematic review of the literature.J Minim Invasive Gynecol,2021,28(3):527-536.
[11]Chevrot A,Pouget N,Bats AS,et al.Fertility and prognosis of borderline ovarian tumor after conservative management:results of the multicentric OPTIBOT study by the GINECO & TMRG group.Gynecol Oncol,2020,157(1):29-35.
[12]Candotti G,Peiretti M,Mangili G,et al.What women want: fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome.Eur J Surg Oncol,2020,46(5):888-892.
[13]李艺,崔恒.卵巢交界性肿瘤术后生育时机妊娠率及分娩后处理.中国实用妇科与产科杂志，2015,31(11):999-1001.
[14]Donnez J,Dolmans MM.Fertility preservation in women.N Engl J Med,2017,377(17):1657-1665.
[15]Candotti G,Peiretti M,Mangili G,et al.What women want:fertility sparing surgery in borderline ovarian tumours patients and pregnancy outcome.Eur J Surg Oncol,2020,46(5):888-892.
[16]Dolmans MM,Donnez J.Fertility preservation in women for medical and social reasons:oocytes vs ovarian tissue.Best Pract Res Clin Obstet Gynaecol,2021,70:63-80.
[17]Masciangelo R,Bosisio C,Donnez J,et al.Safety of ovarian tissue transplantation in patients with borderline ovarian tumors.Hum Reprod,2018,33(2):212-219.
[18]Dolmans MM,von Wolff M,Poirot C,et al.Transplantation of cryopreserved ovarian tissue in a series of 285 women:a review of five leading European centers.Fertil Steril,2021,115(5):1102-1115.
[19]Cobo A,GarciaVelasco JA,Coello A,et al.Oocyte vitrification as an efficient option for elective fertility preservation.Fertil Steril,2016,105(3):755-764.
[20]Uzelac PS,Delaney AA,Christensen GL,et al.Live birth following in vitro maturation of oocytes retrieved from extracorporeal ovarian tissue aspiration and embryo cryopreservation for 5 years.Fertil Steril,2015,104(5):1258-1260.
[21]李建华,范晶晶,焦婷婷,等.多囊卵巢综合征不孕症采用未成熟卵母细胞体外成熟与常规体外受精-胚胎移植技术治疗的疗效比较.中国优生与遗传杂志,2020,28(12):1552-1554.
[22]Dolmans MM,Manavella DD.Recent advances in fertility preservation.J Obstet Gynaecol Res,2019,45(2):266-279.
[23]Cho H,Lee S,Min K,et al.Advances in the treatment and prevention of chemotherapyinduced ovarian toxicity.Int j Mol Sci,2020,21(20):7792.
[24]Li S,Lin H,Xie Y,et al.Live births after in vitro fertilization with fertilitysparing surgery for borderline ovarian tumors:a case series and literature review.Gynecol Obstet Invest,2019,84(5):445-454.
[25]Marklund A,Eloranta S,Wikander I,et al.Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer：a prospective nationwide Swedish multicenter study.Hum Reprod,2020,35(4):929-938.
[26]Filippi F,Martinelli F,Somigliana E,et al.Oocyte cryopreservation in two women with borderline ovarian tumor recurrence.J Assist Reprod Genet,2020,37(5):1213-1216.
[27]Bjrnholt SM,Kjaer SK,Nielsen TS,et al.Risk for borderline ovarian tumours after exposure to fertility drugs:results of a populationbased cohort study. Hum Reprod,2015,30(1):222-231.